JQ1, a BET inhibitor, has been recently reported to induce resistance by increasing FGFR protein expression in ovarian cancer [18] and uveal melanoma [19], but the underlying mechanism remains unclear. This evidence concerns the gene DNER and ovarian carcinoma.